Literature DB >> 23177342

[Pitfalls with 18F-choline PET/CT in patients with prostate cancer].

A M García Vicente1, A Núñez García, A M Soriano Castrejón, G A Jiménez Londoño, J M Cordero García, A Palomar Muñoz.   

Abstract

The (18)F-choline PET-CT (FCH) has better performance in the assessment of patients with prostate cancer than (18)F-FDG. However, similarly, it is also not a tumor specific radiotracer. We present four (18)F-FCH PET-CT scans in which false positive findings were correctly assessed after evaluation with CT, clinical parameters and/or histological analysis.
Copyright © 2011 Elsevier España, S.L. and SEMNIM. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177342     DOI: 10.1016/j.remn.2012.01.005

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN: 2253-654X            Impact factor:   1.359


  4 in total

1.  Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model.

Authors:  Mohammed N Tantawy; H Charles Manning; Todd E Peterson; Daniel C Colvin; John C Gore; Wenfu Lu; Zhenbang Chen; C Chad Quarles
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

Review 2.  F18-choline/C11-choline PET/CT thyroid incidentalomas.

Authors:  Francesco Bertagna; Domenico Albano; Luca Giovanella; Raffaele Giubbini; Giorgio Treglia
Journal:  Endocrine       Date:  2019-01-12       Impact factor: 3.633

3.  18F-choline PET/CT incidental thyroid uptake in patients studied for prostate cancer.

Authors:  Domenico Albano; Rexhep Durmo; Francesco Bertagna; Raffaele Giubbini
Journal:  Endocrine       Date:  2018-12-29       Impact factor: 3.633

4.  Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer.

Authors:  Marina Hodolic; Virginie Huchet; Sona Balogova; Laure Michaud; Khaldoun Kerrou; Valérie Nataf; Marino Cimitan; Jure Fettich; Jean-Noël Talbot
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.